Table 2.
Lesion characteristics distribution among the studied groups.
| MMR group N = 15 |
PPD group N = 15 |
Saline group N = 15 |
Test of significance | Within group significance | |
|---|---|---|---|---|---|
| Duration of disease (months) | 4 (2–6) | 3 (2–6) | 4 (2–6) | KW | P1 = 0.226 |
| P = 0.446 | P2 = 0.8066 | ||||
| P3 = 0.367 | |||||
| Number of lesions | 11 (6–16) | 10 (6–17) | 8 (6–12) | KW | P1 = 0.492 |
| P = 0.051 | P2 = 0.06 | ||||
| P3 = 0.081 | |||||
| Site | |||||
| Trunk | 4 (26.7) | 4 (26.7) | 5 (33.3) | χ2 = 11.35 | |
| Leg | 0 | 2 (13.3) | 2 (13.3) | P = 0.499 | P1 = 0.306 |
| Face & neck | 9 (60) | 8 (53.3) | 5 (33.3) | P2 = 0.375 | |
| Elbow | 0 | 0 | 1 (6.7) | P3 = 0.785 | |
| Arm | 1 (6.7) | 1 (6.7) | 2 (13.3) | ||
| Abdomen | 1 (6.7) | 0 | 0 | ||
KW, Kruskal Wallis test; χ2, Chi-Square test; P1, difference between MMR & PPD group; P2, difference between MMR & Saline group; P3, difference between PPD & Saline group, within group significance was done by Mann Whitney U test.